- Report
- June 2020
- 113 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2617EUR$2,750USD£2,240GBP
- Report
- March 2021
- 101 Pages
Global
€20932EUR$22,000USD£17,923GBP
- Report
- July 2019
- 498 Pages
Global
€20932EUR$22,000USD£17,923GBP
- Report
- April 2018
- 31 Pages
Global
From €9515EUR$10,000USD£8,147GBP
- Report
- April 2018
Global
From €951EUR$1,000USD£815GBP
- Report
- November 2023
- 251 Pages
China
From €3806EUR$4,000USD£3,259GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$3,941USD£3,102GBP
- Report
- January 2024
- 91 Pages
Global
From €3500EUR$3,941USD£3,102GBP
- Report
- May 2024
- 50 Pages
Global
From €2521EUR$2,650USD£2,159GBP
- Report
- October 2022
- 229 Pages
Global
From €3397EUR$3,570USD£2,908GBP
- Report
- July 2022
- 220 Pages
Global
From €3397EUR$3,570USD£2,908GBP
- Report
- April 2024
- 160 Pages
From €5708EUR$5,999USD£4,887GBP
Olanzapine is a medication used to treat mental health conditions such as schizophrenia, bipolar disorder, and depression. It is a member of the atypical antipsychotic class of drugs, which are used to treat the symptoms of mental health conditions. Olanzapine works by blocking certain receptors in the brain, which helps to reduce the symptoms of mental health conditions. It is also used to treat agitation and aggression in people with dementia.
Olanzapine is a widely used medication in the Central Nervous System (CNS) drug market. It is used to treat a variety of mental health conditions, and is often prescribed as a first-line treatment for schizophrenia. It is also used to treat other mental health conditions, such as bipolar disorder and depression. Olanzapine is generally well-tolerated, and has fewer side effects than other antipsychotic medications.
Some companies in the Olanzapine market include Eli Lilly, Pfizer, Novartis, and Teva Pharmaceuticals. Show Less Read more
